. All of the following statements about the use of spironolactone in CHF are true except
(Ref KDT 6/e p507) Loop diuretics are used to provide rapid symptomatic relief whereas aldosterone antagonists decrease the moality by reversing myocardial remodeling
It should be administered in low doses to prevent hyperkalemial
It affords prognostic benefit in severe hea failure over and above that afforded by ACE inhibitors
It helps to overcome the refractoriness to thiazides
It affords rapid symptomatic relief in CHF patients
Other topics and Adverse effects